During the past decade, Novant Health Breast Surgery - Greensboro conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novant Health Breast Surgery - Greensboro" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 3 trials, followed by "Alliance Foundation Trials, LLC." with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "Wake Forest University Health Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Breast Surgery - Greensboro" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Dana-Farber Cancer Institute" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "M.D. Anderson Cancer Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Breast Surgery - Greensboro" are "Anatomic Stage II Breast Cancer AJCC v8" (3 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (3 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (3 trials), "Anatomic Stage IIIA Breast Cancer AJCC v8" (3 trials) and "Prognostic Stage II Breast Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Novant Health Breast Surgery - Greensboro" in a lesser frequency.

Most popular intervention types in "Novant Health Breast Surgery - Greensboro" are "Drug" (4 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab Emtansine" (3 trials), "Pertuzumab" (2 trials), "Quality-of-Life Assessment" (2 trials), "Trastuzumab" (2 trials) and "Active Monitoring" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Breast Surgery - Greensboro" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Novant Health Breast Surgery - Greensboro". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novant Health Breast Surgery - Greensboro, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Breast Surgery - Greensboro, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".